<DOC>
	<DOCNO>NCT01786785</DOCNO>
	<brief_summary>Acute ischemic stroke affect roughly 1 50,000 child every year one top ten cause death child . Currently , caregiver lay affected child flat hop increase blood flow brain reducing volume brain damage . However , currently techniques measure brain blood flow child 's bedside indicate treatment effective . We probe brain blood volume , oxygen saturation , flow red light determine efficacy intervention .</brief_summary>
	<brief_title>Optical Measurement Cerebral Hemodynamics Children With Acute Arterial Ischemic Stroke</brief_title>
	<detailed_description>Arterial ischemic stroke ( AIS ) affect 2 child per 100,000 per year one top 10 cause mortality child . After stroke , disturbance cerebral blood flow ( CBF ) autoregulation , change head position may change CBF . Currently , practice CHOP keep head bed ( HOB ) child AIS flat 24 hour ; however , evidence practice efficacious child . Furthermore , maintain child supine 24 hour uncomfortable child often unenforceable young child . This study use noninvasive optical technique measure CBF HOB position change assess effectiveness head bed position increase CBF child acute arterial ischemic stroke . The primary objective determine difference CBF HOB flat ( 0 degree ) HOB +30 degrees healthy child child AIS . The secondary objective examine CBF healthy child child AIS HOB angle ( 0 , +15 , +30 degrees ) compare CBF HOB 0 degree determine position maximizes CBF varies time stroke onset .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>Inclusion Criteria Healthy Control Subjects 1 . Subjects age 218 year inclusive 2 . No history congenital acquire brain injury 3 . No history developmental delay , mental retardation , genetic metabolic syndrome affect brain Inclusion Criteria AIS Subjects 1 . Subjects age 218 year inclusive 2 . 72 hour less stroke onset 3 . MRI CT confirmation AIS Exclusion Criteria All Subjects 1 . Skull defect prevent application probe 2 . Moyamoya disease 3 . Sickle cell anemia</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>